Szemészeti hatóanyag-felszabadító rendszerek fejlesztési lehetoségei

Translated title of the contribution: Development of ocular drug delivery systems

Zsófia Sáska, Mária Hajdú, Mónika Laki, I. Klebovich, I. Antal

Research output: Contribution to journalArticle

Abstract

Development of controlled drug delivery systems open new vistas in the ophthalmic drug therapy. The use of these systems has benefits for various illnesses of the eye - inflammation caused by exogen infections (uveitis, conjunctivitis, keratitis, keratoconjunctivitis), injury, diseases caused by endogen reasons (Cataracta, glaucoma). In the case of conventional products the reproduction of the doses is difficult, to retain the microbiological stability preservatives have to be employed, these materials are able to deplate the tissues of the eye, for example the cornea. In the aspect of the patients the frequent application of the product, the burning and sciatic feeling by the application of the dosage form can cause problems. The therapeutic systems consist of biocompatible ingredients, they can cover the irritating effect of an agent. Accordingly less drug and less application will be enough to treate the diseases of the eye and the systemic side effects can be avoided.

Original languageHungarian
Pages (from-to)156-164
Number of pages9
JournalActa Pharmaceutica Hungarica
Volume78
Issue number4
Publication statusPublished - 2008

Fingerprint

Drug Delivery Systems
Keratoconjunctivitis
Conjunctivitis
Eye Diseases
Keratitis
Uveitis
Dosage Forms
Glaucoma
Cornea
Cataract
Reproduction
Emotions
Inflammation
Drug Therapy
Wounds and Injuries
Infection
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Szemészeti hatóanyag-felszabadító rendszerek fejlesztési lehetoségei. / Sáska, Zsófia; Hajdú, Mária; Laki, Mónika; Klebovich, I.; Antal, I.

In: Acta Pharmaceutica Hungarica, Vol. 78, No. 4, 2008, p. 156-164.

Research output: Contribution to journalArticle

Sáska, Zsófia ; Hajdú, Mária ; Laki, Mónika ; Klebovich, I. ; Antal, I. / Szemészeti hatóanyag-felszabadító rendszerek fejlesztési lehetoségei. In: Acta Pharmaceutica Hungarica. 2008 ; Vol. 78, No. 4. pp. 156-164.
@article{32e327d2c50b477e8391b2d38d143327,
title = "Szem{\'e}szeti hat{\'o}anyag-felszabad{\'i}t{\'o} rendszerek fejleszt{\'e}si lehetos{\'e}gei",
abstract = "Development of controlled drug delivery systems open new vistas in the ophthalmic drug therapy. The use of these systems has benefits for various illnesses of the eye - inflammation caused by exogen infections (uveitis, conjunctivitis, keratitis, keratoconjunctivitis), injury, diseases caused by endogen reasons (Cataracta, glaucoma). In the case of conventional products the reproduction of the doses is difficult, to retain the microbiological stability preservatives have to be employed, these materials are able to deplate the tissues of the eye, for example the cornea. In the aspect of the patients the frequent application of the product, the burning and sciatic feeling by the application of the dosage form can cause problems. The therapeutic systems consist of biocompatible ingredients, they can cover the irritating effect of an agent. Accordingly less drug and less application will be enough to treate the diseases of the eye and the systemic side effects can be avoided.",
author = "Zs{\'o}fia S{\'a}ska and M{\'a}ria Hajd{\'u} and M{\'o}nika Laki and I. Klebovich and I. Antal",
year = "2008",
language = "Hungarian",
volume = "78",
pages = "156--164",
journal = "Acta Pharmaceutica Hungarica",
issn = "0001-6659",
publisher = "Magyar Gyogyszereszeti Tarsasag",
number = "4",

}

TY - JOUR

T1 - Szemészeti hatóanyag-felszabadító rendszerek fejlesztési lehetoségei

AU - Sáska, Zsófia

AU - Hajdú, Mária

AU - Laki, Mónika

AU - Klebovich, I.

AU - Antal, I.

PY - 2008

Y1 - 2008

N2 - Development of controlled drug delivery systems open new vistas in the ophthalmic drug therapy. The use of these systems has benefits for various illnesses of the eye - inflammation caused by exogen infections (uveitis, conjunctivitis, keratitis, keratoconjunctivitis), injury, diseases caused by endogen reasons (Cataracta, glaucoma). In the case of conventional products the reproduction of the doses is difficult, to retain the microbiological stability preservatives have to be employed, these materials are able to deplate the tissues of the eye, for example the cornea. In the aspect of the patients the frequent application of the product, the burning and sciatic feeling by the application of the dosage form can cause problems. The therapeutic systems consist of biocompatible ingredients, they can cover the irritating effect of an agent. Accordingly less drug and less application will be enough to treate the diseases of the eye and the systemic side effects can be avoided.

AB - Development of controlled drug delivery systems open new vistas in the ophthalmic drug therapy. The use of these systems has benefits for various illnesses of the eye - inflammation caused by exogen infections (uveitis, conjunctivitis, keratitis, keratoconjunctivitis), injury, diseases caused by endogen reasons (Cataracta, glaucoma). In the case of conventional products the reproduction of the doses is difficult, to retain the microbiological stability preservatives have to be employed, these materials are able to deplate the tissues of the eye, for example the cornea. In the aspect of the patients the frequent application of the product, the burning and sciatic feeling by the application of the dosage form can cause problems. The therapeutic systems consist of biocompatible ingredients, they can cover the irritating effect of an agent. Accordingly less drug and less application will be enough to treate the diseases of the eye and the systemic side effects can be avoided.

UR - http://www.scopus.com/inward/record.url?scp=58249105314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58249105314&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:58249105314

VL - 78

SP - 156

EP - 164

JO - Acta Pharmaceutica Hungarica

JF - Acta Pharmaceutica Hungarica

SN - 0001-6659

IS - 4

ER -